144 related articles for article (PubMed ID: 36340606)
1. ASPP2 promotes cell apoptosis in cervical cancer through inhibiting autophagy.
Jiang F; Bian G; Li J
Exp Ther Med; 2022 Dec; 24(6):726. PubMed ID: 36340606
[TBL] [Abstract][Full Text] [Related]
2. [ASPP2 inhibits oxaliplatin-induced autophagy and promotes apoptosis of colon cancer cells].
Wang B; Qiao L; Shi Y; Feng X; Chen D; Guo H
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Jul; 31(7):898-904. PubMed ID: 26146058
[TBL] [Abstract][Full Text] [Related]
3. ASPP2 enhances oxaliplatin (L-OHP)-induced colorectal cancer cell apoptosis in a p53-independent manner by inhibiting cell autophagy.
Shi Y; Han Y; Xie F; Wang A; Feng X; Li N; Guo H; Chen D
J Cell Mol Med; 2015 Mar; 19(3):535-43. PubMed ID: 25534115
[TBL] [Abstract][Full Text] [Related]
4. [Effect of overexpression of apoptosis-stimulating protein 2 of p53 on activation and apoptosis of hepatic stellate cells induced by transforming growth factor-β1 and its mechanism].
Lin MH; Guo XH; Qiao LX; Xie F; Shi Y
Zhonghua Gan Zang Bing Za Zhi; 2019 Nov; 27(11):890-895. PubMed ID: 31941245
[No Abstract] [Full Text] [Related]
5. DNA damage regulated autophagy modulator 1 recovers the function of apoptosis-stimulating of p53 protein 2 on inducing apoptotic cell death in Huh7.5 cells.
Liu D; Li R; Guo X; Pang L; Zang Y; Liu K; Chen D
Oncol Lett; 2018 Jun; 15(6):9333-9338. PubMed ID: 29844830
[TBL] [Abstract][Full Text] [Related]
6. [TP53BP2/ASPP2 inhibits autophagy of HepG2 cells by activating mTOR pathway in a p53-independent manner].
Xu P; Shi H; Jiao Y; Chen D; Shi H
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Nov; 35(11):986-991. PubMed ID: 31878994
[TBL] [Abstract][Full Text] [Related]
7. CHOP mediates ASPP2-induced autophagic apoptosis in hepatoma cells by releasing Beclin-1 from Bcl-2 and inducing nuclear translocation of Bcl-2.
Liu K; Shi Y; Guo X; Wang S; Ouyang Y; Hao M; Liu D; Qiao L; Li N; Zheng J; Chen D
Cell Death Dis; 2014 Jul; 5(7):e1323. PubMed ID: 25032846
[TBL] [Abstract][Full Text] [Related]
8. ASPP2 Coordinates ERS-Mediated Autophagy and Apoptosis Through mTORC1 Pathway in Hepatocyte Injury Induced by TNF-α.
Yao J; Yang H; Wang H; Shi H; Jiao Y; Zhang Y; Chen D; Shi H
Front Pharmacol; 2022; 13():865389. PubMed ID: 35418864
[No Abstract] [Full Text] [Related]
9. Deficiency of apoptosis-stimulating protein two of p53 ameliorates acute kidney injury induced by ischemia reperfusion in mice through upregulation of autophagy.
Ji J; Zhou X; Xu P; Li Y; Shi H; Chen D; Li R; Shi H
J Cell Mol Med; 2019 Apr; 23(4):2457-2467. PubMed ID: 30675758
[TBL] [Abstract][Full Text] [Related]
10. Effects of ASPP2 on proliferation and apoptosis of malignant spinal tumor cells.
Huang W; Li X; Cai L
Int J Clin Exp Pathol; 2017; 10(7):8023-8030. PubMed ID: 31966654
[TBL] [Abstract][Full Text] [Related]
11. Deficiency of apoptosis-stimulating protein 2 of p53 protects mice from acute hepatic injury induced by CCl
Xu P; Yao J; Ji J; Shi H; Jiao Y; Hao S; Chen D; Shi H
Toxicol Lett; 2019 Nov; 316():85-93. PubMed ID: 31513885
[TBL] [Abstract][Full Text] [Related]
12. ASPP2 Plays a Dual Role in gp120-Induced Autophagy and Apoptosis of Neuroblastoma Cells.
Liu Z; Qiao L; Zhang Y; Zang Y; Shi Y; Liu K; Zhang X; Lu X; Yuan L; Su B; Zhang T; Wu H; Chen D
Front Neurosci; 2017; 11():150. PubMed ID: 28392757
[TBL] [Abstract][Full Text] [Related]
13. ASPP2 Inhibits the Profibrotic Effects of Transforming Growth Factor-β1 in Hepatic Stellate Cells by Reducing Autophagy.
Lin M; Chang Y; Xie F; Shi Y; Pang L; Chen D
Dig Dis Sci; 2018 Jan; 63(1):146-154. PubMed ID: 29196956
[TBL] [Abstract][Full Text] [Related]
14. ASPP2 inhibits hepatitis B virus replication by preventing nucleus translocation of HSF1 and attenuating the transactivation of ATG7.
Wang S; Sun Y; Wang Y; Wang A; Kou B; Che Y; Chen D; Zhang Y; Shi Y
J Cell Mol Med; 2021 Jul; 25(14):6899-6908. PubMed ID: 34085409
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of ASPP2 expression alleviates the development of proliferative vitreoretinopathy in a rat model.
Yue YK; Chen XL; Liu S; Liu W
Int J Ophthalmol; 2021; 14(12):1813-1819. PubMed ID: 34926193
[TBL] [Abstract][Full Text] [Related]
16. ASPP2 enhances chemotherapeutic sensitivity through the down-regulation of XIAP expression in a p53 independent manner in hepatocellular carcinoma.
Yang T; Gao Y; Liu D; Wang Y; Wu J; Liu X; Shi Y; Chen D
Biochem Biophys Res Commun; 2019 Jan; 508(3):769-774. PubMed ID: 30528232
[TBL] [Abstract][Full Text] [Related]
17.
Mao J; Tan Z; Pan X; Meng F
Exp Ther Med; 2021 Apr; 21(4):397. PubMed ID: 33680119
[TBL] [Abstract][Full Text] [Related]
18. Silencing of ASPP2 promotes the proliferation, migration and invasion of triple-negative breast cancer cells via the PI3K/AKT pathway.
Wu T; Song H; Xie D; Zhao B; Xu H; Wu C; Hua K; Deng Y; Ji C; Hu J; Fang L
Int J Oncol; 2018 Jun; 52(6):2001-2010. PubMed ID: 29568874
[TBL] [Abstract][Full Text] [Related]
19. ASPP2 attenuates triglycerides to protect against hepatocyte injury by reducing autophagy in a cell and mouse model of non-alcoholic fatty liver disease.
Xie F; Jia L; Lin M; Shi Y; Yin J; Liu Y; Chen D; Meng Q
J Cell Mol Med; 2015 Jan; 19(1):155-64. PubMed ID: 25256142
[TBL] [Abstract][Full Text] [Related]
20. Synergistic inhibitory effects on hepatocellular carcinoma with recombinant human adenovirus Aspp2 and oxaliplatin via p53-independent pathway in vitro and in vivo.
Liu X; Xu J; Wang S; Yu X; Kou B; Chai M; Zang Y; Chen D
Int J Oncol; 2017 Oct; 51(4):1291-1299. PubMed ID: 28902369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
